Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment
Clinical trial NCT04333108 · UNKNOWN
Trial details
- NCT number
- NCT04333108
- Sponsor
- AB Science
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2024-12-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.